Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICE: Home vs Inpatient IV Antibiotics for Cellulitis in Children
NCT02334124Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jan 2015
- Primary completion
- Jun 2017
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of ceftriaxone in cellulitis (2 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Treatment failure rate at 2 days. Started Jan 2015; status: completed.
02
Drugs
ceftriaxone
03
Conditions
cellulitis
Beyond the preview
Go deeper on NCT02334124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334124.